People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...

The researchers conducted and extensive literature search (1945-2014) for randomized, controlled trials that compared anti-anginal drug efficacy for managing stable angina. WASHINGTON, DC—While ...

Please provide your email address to receive an email when new articles are posted on . The study included data on 32,691 patients with stable CAD from the prospective, observational CLARIFY registry.

PARIS — After the first major prospective study to associate percutaneous intervention (PCI) with symptom relief in stable angina captured international attention, a new analysis of the ...

The ASSOCIATE study investigators have reported that the I f current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic ...

June 8, 2010 (Updated June 9, 2010) (Dundee, United Kingdom)— A 40-year-old gout drug has been shown to have anti-ischemic properties and could be an alternative new treatment for the symptoms of ...

Complete revascularization with PCI results in better health status for patients with multivessel, stable CAD than either incomplete revascularization or a conservative strategy of guideline-directed ...

Among patients with stable coronary artery disease (CAD), angina with or without evidence of myocardial ischemia is associated with worse clinical outcomes, but silent ischemia is not, according to a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. PCI improved angina symptoms at 12 weeks vs. a sham ...

The initial management of people diagnosed with stable angina should be optimal drug treatment rather than revascularisation procedures, says the National Institute for Health and Clinical Excellence ...

Are there clinical advantages to augmenting standard therapy for stable ischemic heart disease with an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB)? Adding an ...

People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...